Longbin Liu
Active 1991–2024
- 30
- Papers
- 3,259
- Citations
- 24
- h-index
- 27
- i10-index
Self-citations are included in these numbers.
Citations per year
Citations
Citation sources
Countries
This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.
Institutions
- Amgen (United States)14.1%
- AstraZeneca (United Kingdom)9.3%
- University of Antwerp8.7%
- Chinese Academy of Sciences8.3%
- University of Liverpool8.1%
- CHDI Foundation7.6%
- Other43.9%
Fields
- Biochemistry, Genetics and Molecular Biology35.5%
- Medicine26.2%
- Chemistry17.3%
- Neuroscience7.7%
- Computer Science6.8%
- Pharmacology, Toxicology and Pharmaceutics2.8%
- Other3.8%
Topics
- Protein Kinase Regulation and GTPase Signaling13.6%
- Computational Drug Discovery Methods9.9%
- PI3K/AKT/mTOR signaling in cancer9.3%
- Click Chemistry and Applications9%
- Protein Degradation and Inhibitors7.6%
- Chemical Synthesis and Analysis7%
- Other43.6%
Frequent coauthors
- Celia Dominguez18
- Ignacio Muñoz-Sanjuán14
- Jonathan Bard11
- Daniele Bertoglio9
- Steven Staelens9
- Vinod Khetarpal9
- Jeroen Verhaeghe8
- Alan Miranda7
- Ladislav Mrzljak7
- Mark H. Norman6
- Mette Skinbjerg6
- Ning Xi6
- Christopher J. Brown5
- Frank Herrmann5
- Manuela Heßmann5
- Matthew R. Mills5
- Michael E. Prime5
- Peter Johnson5
- Sabine Schaertl5
- Sigrid Stroobants5
- Tae‐Seong Kim5
- Isabelle Dussault4
- Karen Rex4
- Leonie Wyffels4
All papers
Loading papers…
